Loading company…
The MIP Pharma Group, based in Blieskastel, Germany, develops and distributes antibiotics for specialist physicians and hospitals.
Founded in 1955 and headquartered in Blieskastel, Germany, The MIP Pharma Group develops and distributes pharmaceuticals with a focus on antibiotics. It has 17 locations across Poland and Eastern Europe and is led by CEOs Friedrich Sernetz and Martin Osterhues. In July 2020, the company acquired a majority stake in CNP Pharma GmbH. In 2022 it reported revenue of EUR 51.35 mn and EBITDA of EUR 12.32 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in